CME Group (CME) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
22 Jul, 2026Executive summary
Achieved record annual revenue of $6.5 billion, up 6% year-over-year, with adjusted net income of $4.1 billion and adjusted diluted EPS of $11.20, both up 9%.
Fifth consecutive year of record average daily volume, reaching 28.1 million contracts, with broad-based growth across all asset classes and international markets.
Expanded product innovation, including Event Contracts, FanDuel Predicts, DraftKings Predictions, and new crypto offerings, driving engagement from new retail and institutional clients.
Announced SEC approval for a new securities clearing house, with launch expected in 2026.
Achieved highest Q4 volume on record and second-highest quarterly revenue in company history.
Financial highlights
2025 revenue reached $6.5 billion, up 6% year-over-year, with record revenues in five of six asset classes.
Adjusted net income was $4.1 billion, with adjusted EPS up 9% year-over-year to $11.20.
Q4 revenue was $1.65 billion, up 8% from Q4 2024; adjusted operating margin for the year was 69.4%.
Market data revenue surpassed $800 million for the first time, up 13% year-over-year.
Cash at quarter-end was $4.6 billion, including $1.3 billion in OSTTRA proceeds; debt was $3.4 billion.
Outlook and guidance
2026 adjusted operating expenses (excluding license fees) expected to be ~$1.695 billion, reflecting core growth and investments in new initiatives.
Capital expenditures projected at $85 million; adjusted effective tax rate between 23.5%-24.5%.
Fee adjustments and market data changes expected to increase total revenue by 1%-1.5% on similar activity to 2025.
Focused on expanding access through U.S. Treasury clearing, 24/7 cryptocurrency trading, and prediction markets.
Plans to further increase average daily margin efficiencies for market users.
Latest events from CME Group
- Q2 2026 saw record revenue, strong market data growth, and robust shareholder returns.CME
Q2 202624 Jul 2026 - Record Q1 2026 revenue and net income driven by surging global trading volumes and innovation.CME
Q1 202622 Jul 2026 - S&P 500 ESG Index rebranded as Scores and Screens, fueling growth in liquid ESG investment products.CME
Beyond ESG with Understanding the S&P 500 ESG Index Ecosystem Conference9 Jul 2026 - Strong volumes, new product launches, and tech-driven change shape a dynamic market outlook.CME
Piper Sandler Global Exchange and Trading Conference 20249 Jul 2026 - Record Q2 revenue, net income, and trading volumes with broad-based growth and innovation.CME
Q2 20248 Jul 2026 - Director election amendments failed; all nominated directors reelected; no shareholder questions.CME
AGM 20269 Jun 2026 - CFTC's Bitcoin perpetual approval sparks risk warnings amid new product launches and efficiency focus.CME
Piper Sandler Global Exchange and Fintech Conference4 Jun 2026 - Class B Proposals seek to modernize board structure and offer payments to shareholders if approved.CME
Proxy filing19 May 2026 - Board candidates stress governance, risk oversight, and shareholder advocacy for the 2026 meeting.CME
Proxy filing16 Apr 2026